IG
BMRN icon

Ithaka Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Ithaka Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-51,407
Closed -$4.38M – 37
2018
Q4 		$4.38M Sell
51,407
-2,823
-5% -$269K 0.8% 30
2018
Q3 		$5.26M Sell
54,230
-4,396
-7% -$439K 0.78% 30
2018
Q2 		$5.52M Sell
58,626
-1,015
-2% -$88.9K 0.86% 30
2018
Q1 		$4.83M Buy
59,641
+59,628
+458,677% +$5.12M 0.81% 30
2017
Q4 		$5.37M Sell
13
-61,751
-100% -$5.37M 0.96% 30
2017
Q3 		$5.75M Sell
61,764
-3,083
-5% -$272K 1.06% 31
2017
Q2 		$5.89M Sell
64,847
-18
-0% -$1.64K 1.07% 32
2017
Q1 		$5.69M Sell
64,865
-3,733
-5% -$332K 1.1% 33
2016
Q4 		$5.68M Sell
68,598
-14,991
-18% -$1.29M 1.12% 31
2016
Q3 		$7.73M Buy
83,589
+25,026
+43% +$2.36M 1.22% 32
2016
Q2 		$4.56M Sell
58,563
-584
-1% -$49.6K 0.66% 36
2016
Q1 		$4.88M Buy
59,147
+1,801
+3% +$147K 0.7% 33
2015
Q4 		$6.01M Buy
57,346
+3,489
+6% +$364K 0.8% 32
2015
Q3 		$5.67M Buy
53,857
+6,569
+14% +$877K 0.87% 36
2015
Q2 		$6.47M Sell
47,288
-3,073
-6% -$381K 1.09% 34
2015
Q1 		$6.28M Buy
+50,361
New +$5.34M 0.99% 33

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ithaka Group's BMRN Position: Q1 2019 in Review

Ithaka Group sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2019, closing a stake of 51,407 shares — an estimated $4.38M sold.

Ithaka Group first reported a position in BMRN in Q1 2015 and held it in 16 quarters. The position peaked at $7.73M in Q3 2016. 485 funds tracked by Wall St. Rank hold BMRN as of Q1 2019.

  • Ithaka Group reported no remaining BioMarin Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Ithaka Group sold 51,407 BioMarin Pharmaceuticals shares in Q1 2019, an estimated $4.38M.
  • Ithaka Group first reported a position in BioMarin Pharmaceuticals in Q1 2015 and held it in 16 quarters.
  • Ithaka Group's BioMarin Pharmaceuticals position peaked at $7.73M in Q3 2016.
  • 485 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2019.

Based on Ithaka Group's 13F filing for Q1 2019, filed 13 May 2019.